Understand the source comparison
Real Peptides FOXO4-DRI vs Competitors Quality: Comparison Table
Before committing to a supplier, compare these quality markers. They determine whether your FOXO4-DRI produces reproducible results or wastes your sample budget. Synthesis Method Small-batch SPPS with per-cycle Kaiser test verification High-volume liquid-phase
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before committing to a supplier, compare these quality markers. They determine whether your FOXO4-DRI produces reproducible results or wastes your sample budget.
- Synthesis Method
- Small-batch SPPS with per-cycle Kaiser test verification
- High-volume liquid-phase synthesis, post-production sampling only
- Small-batch SPPS, no per-cycle verification disclosed
- Real Peptides' per-cycle verification catches sequence errors before final purification. Competitors detect errors only after the batch is complete, if at all
- Purity Verification
- Third-party HPLC + MALDI-TOF mass spec on every batch
- In-house HPLC, single mass spec per product line
- Third-party HPLC only, mass spec on request
- Mass spec is non-negotiable for detecting deletion mutants. HPLC alone measures total peptide but not sequence fidelity
- Endotoxin Testing
- LAL assay every batch, <1 EU/mg guaranteed
- Not disclosed, available on request
- No endotoxin data provided
- Endotoxin above 1 EU/mg activates NF-κB independently of FOXO4-DRI mechanism. Untested peptides risk false-positive apoptosis results
- Cold-Chain Shipping
- Insulated packaging, 2–8°C gel packs, 48-hour delivery, temp data loggers over $500
- Standard ground shipping, no temperature monitoring
- Insulated packaging, no temp verification
- Temperature excursions above 10°C cause irreversible peptide denaturation. Shipping without monitoring means degradation occurs before you open the vial
- Reconstitution Guidance
- Detailed protocol with stabiliser recommendations, storage duration specs
- Basic water/PBS instruction only
- No reconstitution protocol provided
- Without stabilisers, reconstituted FOXO4-DRI degrades 30–40% within 72 hours. Proper guidance prevents wasted aliquots
- Batch-to-Batch Variance
- <3% purity variance across batches (third-party verified)
- Not disclosed
- 5–8% variance (inferred from customer reports)
- Variance above 5% compromises reproducibility. A 92% pure batch and a 98% pure batch produce different dose-response curves